The pharmaceutical giant Pfizer said Tuesday that a new
coronavirus vaccine could be tested as early as next week
Pfizer is working with German-based BioNtech to deliver the
possible vaccine. Clinical trials on human volunteers in Germany have already
started.
Health regulators in the US may approve testing the vaccine
on humans by next week, Bourla told the paper.
If that timeline holds true, study results could be
delivered within a month. Then, with favorable testing outcomes, the vaccine
may be ready to distribute in emergency cases by the fall, Bourla said.
The New York-based corporation has invested $650 million
into developing and possibly manufacturing the vaccine.
“You can imagine the demand for something like that will be
extremely, extremely high,” Bourla told the Journal.
But the odds of developing a successful vaccine are slim,
with just 6 percent of them becoming market-ready after a series of strict
tests, the report said, citing a 2013 study published by PLOS ONE. (Realtalktime)
Post a Comment
We want to know your comments and concerns. Remember: Respect distinguishes us, education makes us different...